1586 (1586) Fair Value & Analysis

Industrials · Market cap HK$990M

1 1586 1586 · HK

PriceHK$1.77

Fair ValueHK$1.06

Upside-40.1%

Quality47/100

Watch 1586 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.7900 – HK$1.32

Fair value as of: Jul 2, 2026

From 16 valuation models · updated today

Share price +4.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$1.26 – HK$3.24 · fair‑value band HK$0.7900 – HK$1.32 · the HK$1.77 price screens above the HK$1.06 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1586 (1586) currently trades at HK$1.77, while our model-based Fair Value estimate is HK$1.06 — implying the stock looks roughly 40.1% overvalued today. We read business quality at 47/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1586 generated revenue of HK$1.3B at a net margin of 2.9%. Revenue grew 13.4% year over year. It earns a return on equity of 10.6%. Net debt stands at HK$3.8M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.3B

Revenue growth (YoY) +13.4%

Net margin 2.9%

Return on equity 10.6%

Free cash flow −HK$17.6M FY2025

P/E ratio 25.3

More key figures

Operating margin 3.6%

EPS (TTM) HK$0.0700

EPS growth (YoY) -21.1%

Net debt HK$3.8M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1586 reported revenue of HK$1.2B in FY2025 versus HK$819M in FY2021, a compound +10.1%/yr. Reported net income was HK$34.8M in FY2025, compounding −8.6%/yr from FY2021.

Revenue +10.1%/yr

FY21 HK$819M

FY22 HK$829M

FY23 HK$1.0B

FY24 HK$1.2B

FY25 HK$1.2B

Net income −8.6%/yr

FY21 HK$49.8M

FY22 HK$60.9M

FY23 HK$72.5M

FY24 HK$77.7M

FY25 HK$34.8M

Is 1586 fairly valued? → Check now

Similar stocks

6 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Cintas Corporation CTAS	$180.40	$74.70	-59%
RELX PLC R1EL34	R$39.80	R$4.72	-88%
Thomson Reuters Corporation TRI	C$114.51	C$85.90	-25%
Copart, Inc CPRT	$29.48	$34.05	+16%
Global Payments Inc GPN	$62.47	$51.51	-18%
UL Solutions Inc ULS	$97.38	$29.61	-70%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1586 (1586) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$1.06 versus a price of HK$1.77 — about −40% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1586?

Our model-based fair value for 1586 is HK$1.06 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.77.

What is the quality score of 1586?

1586 has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1586 (1586)?

1586 reported trailing-twelve-month revenue of about HK$1.3B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1586?

The net profit margin of 1586 is about 2.9%, meaning it keeps roughly 2.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.